Search
InsiderInsights.com

Rawcliffe Adrian (1555851)

Rawcliffe Adrian has been a registered insider since 2003. As Chief Executive Officer at Adaptimmune Therapeutics plc , Rawcliffe Adrian last made a transaction on 1/17/2025.

(ADAP)

Titles: CEO,DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
22 82% -16% -44% 433 1 Year 22 0% -- -- --
22 73% -1% -41% 635 9 Month 22 0% -- -- --
22 77% 17% -34% 716 6 Month 22 0% -- -- --
22 77% -11% -24% 169 3 Month 22 0% -- -- --
25 68% 8% -4% 271 1 Month 25 0% -- -- --
25 64% 6% -4% 234 1 Week 25 0% -- -- --
Scorecards Updated 4/3/2025 06:20 PM EST Latest Transaction Date: 1/17/2025
Average days between Transaction and Entered Dates: 1
© 2025 InsiderInsights.com